Amundi Astrazeneca PLC Transaction History
Amundi
- $276 Billion
- Q2 2025
A detailed history of Amundi transactions in Astrazeneca PLC stock. As of the latest transaction made, Amundi holds 10,274 shares of AZN stock, worth $798,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,274
Previous 6,656
54.36%
Holding current value
$798,187
Previous $489,000
46.63%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.04 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.2 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.67 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.44 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.42 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...